Back to search

Article

The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

2019-11-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> After long-term androgen deprivation therapy, 25-30% prostate cancer (PCa) acquires an aggressive neuroendocrine (NE) phenotype. Dysregulation of YAP1, a key transcription coactivator of the Hippo pathway, has been related to cancer progression. However, its role in neuroendocrine prostate cancer (NEPC) has not been assessed. <h4>METHODS</h4> Immunohistochemistry was used t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c16fa5f6-8086-58f6-8b42-233732c20bf5
DOI
10.1101/832360
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancerDOI 10.1101/832360
Select a neighboring publication to make it the new centre.